- Home
- SAGE vs BLZE Comparison
SAGE vs BLZE Comparison
Compare SAGE & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- BLZE
- Stock Information
- Founded
- SAGE 2010
- BLZE 2007
- Country
- SAGE United States
- BLZE United States
- Employees
- SAGE N/A
- BLZE N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- BLZE Computer Software: Prepackaged Software
- Sector
- SAGE Health Care
- BLZE Technology
- Exchange
- SAGE Nasdaq
- BLZE Nasdaq
- Market Cap
- SAGE 444.1M
- BLZE 381.2M
- IPO Year
- SAGE 2014
- BLZE 2021
- Fundamental
- Price
- SAGE $7.31
- BLZE $7.21
- Analyst Decision
- SAGE Hold
- BLZE Strong Buy
- Analyst Count
- SAGE 20
- BLZE 4
- Target Price
- SAGE $10.67
- BLZE $11.50
- AVG Volume (30 Days)
- SAGE 1.8M
- BLZE 369.2K
- Earning Date
- SAGE 02-11-2025
- BLZE 02-25-2025
- Dividend Yield
- SAGE N/A
- BLZE N/A
- EPS Growth
- SAGE N/A
- BLZE N/A
- EPS
- SAGE N/A
- BLZE N/A
- Revenue
- SAGE $41,243,000.00
- BLZE $122,579,000.00
- Revenue This Year
- SAGE $123.13
- BLZE $27.53
- Revenue Next Year
- SAGE $69.65
- BLZE $14.73
- P/E Ratio
- SAGE N/A
- BLZE N/A
- Revenue Growth
- SAGE N/A
- BLZE 27.41
- 52 Week Low
- SAGE $4.62
- BLZE $4.91
- 52 Week High
- SAGE $23.22
- BLZE $12.65
- Technical
- Relative Strength Index (RSI)
- SAGE 60.55
- BLZE 58.03
- Support Level
- SAGE $7.00
- BLZE $7.01
- Resistance Level
- SAGE $7.26
- BLZE $7.83
- Average True Range (ATR)
- SAGE 0.19
- BLZE 0.42
- MACD
- SAGE -0.06
- BLZE 0.06
- Stochastic Oscillator
- SAGE 57.14
- BLZE 70.19
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and other regions.